Last: | $7 |
---|---|
Change Percent: | 0.0% |
Open: | $7 |
Close: | $7 |
High: | $7 |
Low: | $7 |
Volume: | 8,606 |
Last Trade Date Time: | 09/28/2021 11:27:03 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7 | $7 | $7 | $7 | $7 | 8,606 | 09-28-2021 |
$7 | $7.0115 | $7 | $7.08 | $6.85 | 40,161 | 09-27-2021 |
$7.01 | $6.82 | $7.01 | $7.01 | $6.82 | 19,223 | 09-24-2021 |
$7.08 | $6.85 | $7.08 | $7.08 | $6.85 | 10,363 | 09-23-2021 |
$6.9287 | $6.9 | $6.9287 | $7.0726 | $6.8201 | 7,851 | 09-22-2021 |
$6.9449 | $7 | $6.9449 | $7 | $6.82 | 6,828 | 09-21-2021 |
$7.1 | $7.3 | $7.1 | $7.3 | $6.9796 | 9,542 | 09-20-2021 |
$7.25 | $6.95 | $7.25 | $7.25 | $6.65 | 22,269 | 09-17-2021 |
$7.0406 | $7.18 | $7.0406 | $7.2487 | $6.95 | 15,203 | 09-16-2021 |
$7.24 | $7.08 | $7.24 | $7.35 | $7.08 | 4,462 | 09-15-2021 |
$7.1596 | $7.1 | $7.1596 | $7.1596 | $7 | 8,580 | 09-14-2021 |
$7 | $7.33 | $7 | $7.33 | $7 | 28,799 | 09-13-2021 |
$7.32 | $7.0001 | $7.32 | $7.32 | $7.0001 | 15,001 | 09-10-2021 |
$7 | $7.1 | $7 | $7.1 | $7 | 10,352 | 09-09-2021 |
$7.15 | $7.25 | $7.15 | $7.3307 | $7.1 | 8,097 | 09-08-2021 |
$7.35 | $7.59 | $7.35 | $7.59 | $7.28 | 2,687 | 09-07-2021 |
$7.53 | $7.69 | $7.53 | $7.69 | $7.4901 | 11,544 | 09-06-2021 |
$7.53 | $7.69 | $7.53 | $7.69 | $7.4901 | 11,544 | 09-03-2021 |
$7.6109 | $7.7 | $7.6109 | $7.7 | $7.6109 | 6,939 | 09-02-2021 |
$7.6273 | $7.52 | $7.6273 | $7.7 | $7.4701 | 8,845 | 09-01-2021 |
News, Short Squeeze, Breakout and More Instantly...
Taiwan Liposome Company Ltd. Company Name:
TLC Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed findings from the Phase 3 clinical trial of TLC599 at the American College of Rheumatology (ACR) Annual...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharma...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the Abstract Sele...